Surgical resection is the first-line therapy for most benign cardiac tumors, whereas cardiac sarcomas and metastatic tumors require multimodal treatment and carry a poor prognosis.
Cardiac tumors require tailored management strategies, with surgical resection favored for benign tumors and multimodal approaches necessary for malignant subtypes.
Cardiac tumors are rare and encompass a variety of presentations. Clinica symptoms are usually nonspecific, but they can present as obstructive, embolic, or constitutional symptoms. Treatment options and prognosis vary highly depending on the subtype, tumor size, and location. Surgical resection is usually the first-line therapy, except for cardiac lymphomas, and provides favorable long-term prognosis in most benign tumors. Cardiac sarcomas, however, are usually diagnosed in advanced stages, and the treatment relies on a multimodal approach with chemotherapy and radiotherapy. Metastatic cardiac tumors are usually related to advanced disease and carry an overall poor prognosis.
Karigyo et al. (Mon,) conducted a review in Cardiac tumors. Surgical resection, chemotherapy, and radiotherapy was evaluated. Surgical resection is the first-line therapy for most benign cardiac tumors, whereas cardiac sarcomas and metastatic tumors require multimodal treatment and carry a poor prognosis.